Defendant
1 case as defendant.
Company overview. BI Science (2009) Ltd., commonly branded BIScience, is a private, venture-backed data-analytics company founded in 2009 and headquartered at 6 Hanechoshet Street, Tel Aviv, Israel, with small sales offices in New York and Ukraine (and a listed Australia location). It was founded by Kfir Moyal, Assaf Toval and Orey Gilliam. WPP's Kantar Media took a stake in 2015, and the company has raised roughly $12–24M across rounds, per PitchBook and Crunchbase. Headcount estimates vary by source and date — from about 60 (a 2019 court declaration by co-founder Moyal) to 122–150 in recent third-party databases; revenue is not publicly disclosed, with one aggregator estimating ~$13M.
Products / services. BIScience sells digital and behavioral data intelligence for the online advertising industry. Its main line is AdClarity, an ad-intelligence platform covering display, programmatic, social, mobile and video campaigns across many geographies; it also offers consumer-behavior analytics, brand monitoring and web data-extraction products. Historically it sold GeoSurf, a browser add-on/VPN/API proxy service that let media buyers view geo-targeted content; the company announced in May 2020 that it would discontinue the proxy business and transition customers to Luminati.
Patent-litigation posture. BIScience is an operating company, not a patent assertion entity. In the tracked data it appears only as a defendant (0 plaintiff cases, 1 defendant case), consistent with a company defending itself. All tracked activity sits in the plaintiff-friendly U.S. District Court for the Eastern District of Texas, Marshall Division.
Notable cases / context. The dispute is Luminati Networks Ltd. v. BI Science (2009) Ltd. (E.D. Tex., 2:18-cv-00483, and follow-on suits 2:19-cv-352 and 2:19-cv-397), in which proxy provider Luminati alleged infringement of residential-proxy patents plus trade-secret misappropriation and tortious interference. BIScience counterclaimed for false advertising and monopolization, sought transfer to New York, and appealed to the Federal Circuit (No. 20-2118). The parties announced a mutual resolution in May 2020, with BIScience exiting the proxy business. BIScience also holds a small portfolio (~25–27 U.S. patents/applications), including multisession-analysis filings.
Action asserting the '614 patent and the '511 patent against BI Science; filed 12/06/2019 and consolidated into lead case 2:19-cv-00395-JRG. It was substantially resolved by a February 24, 2020 settlement agreement and an April 29, 2020 arbitration award, and was listed as closed.